Hypermethylation of the Myf-3 gene in human colorectal cancer

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 429-432

  Iacopetta, Barry J ^a   Harmon, Donna ^a   Spagnolo, Dominic V ^b   House, Anthony K ^a   Kay, Peter H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Colorectal cancer; Hypermethylation; Myf 3

Indexed keywords

DNA; DNA BINDING PROTEIN;

ADENOCARCINOMA; ADENOMA; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; GENE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS; DNA METHYLATION; HUMANS; MYOD PROTEIN;

EID: 0031059194     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jones PA and Buckley JD: The role of methylation in cancer. Adv Cancer Res 54: 1-23, 1990.
2. Baylin SB, Makos M, Wu J et al: Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 3: 383-390, 1991.
3. Goelz SE, Vogelstein B, Hamilton S et al: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187-190, 1985.
4. Silverman AL, Park JG, Hamilton SR et al: Abnormal methylation of the calcitonin gene in human colonic neoplasms. Cancer Res 49: 3466-3473, 1989.
5. Baylin SB, Hoppener JW, De Bustros A et al: DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res 46: 2917-2922, 1986.
6. Jones PA, Wolkowicz MJ, Rideout WM et al: de novo methylation of the MyoD 1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87: 6117-6121, 1990.
7. Rideout WM, Eversole-Cire P, Spruck C et al: Progressive increases in the methylation status and heterochromatization of the myoD CpG island during oncogenic transformation. Mol Cell Biol 14: 6143-6152, 1994.
8. Sakai T, Toguchida J, Ohtani N et al: Allele-specific hypermethylation of the retinoblastoma tumour-suppressor gene. Am J Hum Genet 48: 880-888, 1991.
9. Ohtani-Fujita N, Fujita T, Aoike A et al: CpG mcthylation inactivates the promoter activity of the human retinoblastoma tumor suppressor gene. Oncogene 8: 1063-1067, 1993.
10. Lee W-H, Morton RA, Epstein JI et al: Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 97: 11733-11737, 1994.
11. Herman JG, Latif F, Weng Y et al: Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704, 1994.
12. Issa J-P, Vertino PM, Wu J et al: Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85: 1235-1240, 1993.
13. Makos-Wales M, Biel MA, El-Deiry W et al: p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nature Medicine 1: 570-577, 1995.
14. Merlo A, Herman JG, Mao L et al: 5Ï CpG island methylation is associated with transriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine 1: 686-692, 1995.
15. Herman JG, Merlo A, Mao L et al: Inactivation of the CDKN2/p16/MTS 1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530, 1995.
16. Braun E, Bober E, Buschhausen-Denker G et al: Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J 8: 3617-3625, 1989.
17. Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000, 1987.
18. Crescenzi M, Fleming TP, Lassar AB et al: MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc Natl Acad Sci USA 87: 8442-8446, 1990.
19. Sorrentino VR, Peperkok R, Davis RL et al: Cell proliferation inhibited by MyoD. Nature 345: 813-815, 1990.
20. Kay PH, Taylor J, Kees UR et al: Myf-3 hypermethylation in malignant lymphoproliferative disorders. Int J Cancer 62: 797-799, 1995.
21. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982.
22. McClelland M, Nelson M: The effect of site-specific DNA methylation on restriction endonucleases and DNA modification methyltransferases- a review. Gene 74: 291-304, 1988.
23. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 95: 503-509, 1975.
24. El-Deiry WS, Nelkin BD, Celano P et al: High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88: 3470-3474, 1991.
25. Issa J-P, Ottaviano YL, Celano P et al: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genetics 7: 536-540, 1994.
26. Steenman MJC, Rainier S, Dobry CJ et al: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilm's tumour. Nature Genetics 7: 433-439, 1994.
27. Makos M, Nelkin BD, Lerman MI et al: Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89: 1929-1933, 1992
28. Kern SE, Fearon ER, Tersmette KWF et al: Allelic loss in colorectal carcinoma. J Am Med Assoc 261: 3099-3103, 1989.
29. Laird PW, Jackson-Grusby L, Fazeli A et al: Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197-205, 1995.